Management of diabetes and hyperglycaemia in non-intensive care units
Research output: Contribution to journal › Review › Research › peer-review
Documents
- Fulltext
Final published version, 333 KB, PDF document
Diabetes and hyperglycaemia are frequent diagnoses in the hospital, and in-hospital hyperglycaemia is associated with adverse clinical outcomes. Insulin is the preferred treatment for in-hospital hyperglycaemia. This review summarises the management of hyperglycaemia in Danish hospitals. In Denmark, sliding-scale insulin is often applied with the addition of basal insulin after 1-2 days with hyperglycaemia which differs from international guidelines recommending a basal-bolus regimen. The optimal non-intensive care unit glucose targets, the safety and efficacy level of non-insulin antidiabetic agents, and continuous glucose monitoring are subjects of further research.
Original language | Danish |
---|---|
Journal | Ugeskrift for Laeger |
Volume | 185 |
Issue number | 6 |
Number of pages | 8 |
ISSN | 0041-5782 |
Publication status | Published - 2023 |
Links
- https://content.ugeskriftet.dk/sites/default/files/2023-02/V11220699_WEB.pdf
Final published version
ID: 389959539